|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 49/00 | |||
| A61K 35/17 | |||
| C07K 16/28 | |||
| C07K 16/32 | |||
| C07K 14/735 | |||
| G01N 33/50 | |||
| A61K 35/12 | |||
| C12N 5/0783 |
| (11) | Patento numeris | 2801583 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14171739.7 |
| Europos patento paraiškos padavimo data | 2005-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 586581 P | 2004-07-10 | US |
| (72) |
Campbell, Kerry S., US
|
| (73) |
Fox Chase Cancer Center,
333 Cottman Avenue, Philadelphia, PA 19111-2497,
US
|
| (54) | Genetically modified human natural killer cell lines |
| Genetically modified human natural killer cell lines |